You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
人福醫藥(600079.SH):股東增加一致行動人
格隆匯 07-10 17:29

格隆匯7月10日丨人福醫藥(600079.SH)公佈,近日收到股東招商生命科技(武漢)有限公司(簡稱“招商生科”)、招商生科投資發展(武漢)合夥企業(有限合夥)(簡稱“生科投資發展”)、中糧信託-春泥1號破產重整服務信託(簡稱“春泥1號”)、武漢高科國有控股集團有限公司(簡稱“武漢高科”)編制的《人福醫藥集團股份公司詳式權益變動報吿書》及招商生科與武漢高科簽署的《協議書》,招商生科與武漢高科雙方達成在該《協議書》項下的一致行動關係。

本次權益變動前,招商生科、生科投資發展、春泥1號原已合計控制人福醫藥403,089,608股股份、佔公司總股本的24.70%對應的表決權,截至本報吿披露日,因招商生科與武漢高科(持有公司26,187,208股股份,佔公司總股本的1.60%)簽署關於一致行動安排的《協議書》,合併計算招商生科、生科投資發展、春泥1號及一致行動人武漢高科持股比例由24.70%上升至26.30%。本次權益變動未觸及要約收購。本次權益變動不觸及控股股東和實際控制人發生變化。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account